MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P10
Near historical low
vs 2Y Ago
-0.5x
Contraction
Streak
4 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -14.71% |
| Q3 2025 | -1.25% |
| Q2 2025 | -0.82% |
| Q1 2025 | 19.58% |
| Q4 2024 | 25.00% |
| Q3 2024 | 6.66% |
| Q2 2024 | 1.62% |
| Q1 2024 | -1.80% |
| Q4 2023 | 28.55% |
| Q3 2023 | 20.29% |
| Q2 2023 | -18.75% |
| Q1 2023 | 3.55% |
| Q4 2022 | -7.29% |
| Q3 2022 | -8.09% |
| Q2 2022 | 13.93% |
| Q1 2022 | -40.90% |
| Q4 2021 | 65.87% |
| Q3 2021 | 98.87% |
| Q2 2021 | 2891.07% |
| Q1 2021 | -6.60% |
| Q4 2020 | 0.00% |